Status:
COMPLETED
Desflurane Preconditioning in Hepatectomies
Lead Sponsor:
Aristotle University Of Thessaloniki
Conditions:
Ischemia Reperfusion Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hepatectomies are considered as operations of high bleeding risk. The history of massive hemorrhage in liver surgery led to the emergence of techniques to control excessive blood loss. These technique...
Detailed Description
Hepatectomies are characterized by an elevated risk of severe hemorrhage. The high vascular supply of the liver has historically troubled surgeons who resolved to techniques to control excessive blood...
Eligibility Criteria
Inclusion
- hepatectomy of at least two segments
Exclusion
- Hepatitis B, C or HIV infection
- liver cirrhosis
- autoimmune disease, inflammatory bowel disease
- pregnancy
- prior additional ablation therapies (cryosurgery or radiofrequency)
- liver resections without inflow occlusion
Key Trial Info
Start Date :
April 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT03848780
Start Date
April 1 2016
End Date
June 30 2018
Last Update
February 21 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.